Hyperfiltration of renal injury: Pathophysiology and clinical implications

Urology

Volumn 47, Issue 2, 1996, Pages 273-283

  Grady, R W ^a   Novick, A C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; KIDNEY FAILURE; KIDNEY INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ULTRAFILTRATION;

EID: 0029978218     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80435-X     Document Type: Review

References (133)

1. Feehally J, Harris KP, Bennett SE, and Walls J: Is chronic transplant rejection a nonimmunological phenomenon? Lancet 2: 486-488, 1986.
2. Brenner BM, Meyer TW, and Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652-659, 1982.
3. Meyer TW, Scholey JW, and Brenner BM: Nephron adaptation to renal injury, in Brenner BM, Rector FC (Eds): The Kidney Fourth Edition. Philadelphia, WB Saunders Co, 1991, p 1871.
4. Threlfall GM, Taylor DM, and Buck AT: Studies of changes in growth and DNA synthesis in the rat kidney during experimentally induced renal hypertrophy. Am J Pathol 50: 1-14, 1967.
5. Goss RJ, and Rankin M: Physiologic factors affecting renal hyperplasia in the rat. J Exp Zool 145: 209, 1960.
6. Johnson HA, and Vera Roman JM: Compensatory renal enlargement. Hypertrophy versus hyperplasia. Am J Pathol 49: 1-13, 1966.
7. Kaufman JM, Hardy R, and Hayslett JP: Age-dependent characteristics of compensatory renal growth. Kidney Int 8: 21-26, 1975.
8. Larson L, Aperia A, and Wilton P: Effect of normal development on compensatory renal growth. Kidney Int 18: 29-35, 1980.
9. Hayslett JP: Effect of age on compensatory renal growth. Kidney Int 23: 599-602, 1983.
10. Rous SN, and Wakim KG: Kidney function before, during, and after compensatory hypertrophy. J Urol 98: 30-35, 1967.
11. Bricker NS: On the meaning of the intact nephron hypothesis. Am J Med 46: 1-11, 1969.
12. Bricker NS, and Fine LG: The renal response to progressive nephron loss, in Brenner BM, Retor CF Jr (Eds): The Kidney, 2nd ed. Philadelphia, WB Saunders, 1981, p 1056.
13. Carriere S, and Gagnon-Brunette M: Compensatory renal hypertrophy in dogs: single nephron glomerular filtration rate. Can J Physiol Pharmacol 55: 105-110, 1977.
14. Boner G, Shelp WD, Newton M, and Rieselbah RE: Factors influencing the increase in glomerular filtration rate in the remaining kidney of transplant donors. Am J Med 55: 169-174, 1973.
15. Kaufman JM, Siegel NJ, and Hayslett JP: Functional and hemodynamic adaptation to progressive renal ablation. Circ Res 36: 286-293, 1975.
16. Hostetter TH, Olson JL, Rennke HG, Ven Katachalam MA, and Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241: F85-F93, 1981.
17. Anderson S, Meyer TW, Rennke HG, and Brenner B: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985.
18. Imbert MJ, Berjal G, Moss N, Rouffignac C, and Bonvalet JP: Number of nephrons in hypertrophic kidneys after unilateral nephrectomy in young and adult rats. A functional study. Pflugers Arch 346: 279-290, 1974.
19. Bonvalet JP: Evidence of induction of new nephrons in immature kidneys undergoing hypertrophy. Yale J Biol Med 51: 315-319, 1978.
20. Deen WM, Maddox DA, Robertson CR, and Brenner BM: Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol 227: F556-F562, 1974.
21. Finn WF: Compensatory renal hypertrophy in Sprague-Dawley rats: glomerular ultrafiltration dynamics. Renal Physiol Biochem 5: 222-224, 1982.
22. Meyer TW, and Rennke HG: Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol 254: F856-F862, 1988.
23. Schweitzer G, and Gertz KH: Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats. Kidney Int 15: 134-143, 1979.
24. Brown SA, Finco DR, and Navar LG: Renal and glomerular hemodynamics in 3/4 nephrectomized dogs. Kidney Int 35: 424, 1989.
25. Neuringer JR, and Brenner BM: Hemodynamic theory of progressive renal disease: a 10-year update in brief review. Am J Kidney Dis 22: 98-104, 1993.
26. Anderson S, and Brenner BM: Intraglomerular hypertension: implications and drug treatment. Annu Rev Med 39: 243-253, 1988.
27. Anderson S, Rennke HG, Garcia DL, and Brenner BM: Short and long-term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36: 526-536, 1989.
28. Neugarten J, Kaminetsky B, Feiner H, Scacht RG, Liu DT, and Baldwin DS: Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy. Kidney Int 28: 135-139, 1985.
29. Meyer TW, and Rennke HG: Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol 254: F856-F862, 1988.
30. Nath KA, Kren SM, and Hostetter TH: Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction. J Clin Invest 78: 1199-1205, 1986.
31. Garcia DL, Anderson S, Rennke HG, and Brenner BM: Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA 85: 6142-6146, 1988.
32. Kasiske BL, O'Donnel MP, Schmitz PG, Kim Y, and Keane WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37: 880-891, 1990.
33. Mitch WE: Measuring progression of renal insufficiency, in WE Mitch (Ed): The Progressive Nature of Renal Disease. New York, Churchill Livingstone, 1985, p 167.
34. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, and Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241: F85-F93, 1981.
35. Hostetter TH, and Mitch WE: Protein intake and prevention of chronic renal disease, in Schrier RW, and Gottschalk CW (Eds): Diseases of the Kidney Fifth Edition. Boston, Little Brown and Company, 1992, pp 3131-3152.
36. Smith LJ, Rosenberg ME, and Hostetter TH: Effect of angiotensin II blockade on dietary protein-induced renal growth. Am J Kidney Dis 22: 120-127, 1993.
37. Don BR, Wada L, Kaysen GA, and Schambelan M: Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome. Kidney Int 36: S163-S167, 1989.
38. Kauffman JM, and Caro JF: Insulin resistance in uremia: characterization of insulin action, binding, and processing in isolated hepatocytes from chronic uremic rats. J Clin Invest 71: 698-708, 1983.
39. Lucas PA, Meadows JH, Roberts DE, and Coles GA: The risks and benefits of a low protein-essential amino acid-keto acid diet. Kidney Int 29: 995-1003, 1986.
40. Hostetter TH, Meyer TW, Rennke HG, and Brenner BM: Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 30: 509-517, 1986.
41. O'Donnell MP, Kasiske BL, Schmitz PG, and Keane WF: High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics. Kidney Int 37: 1263-1269, 1990.
42. Maroni BJ, and Mitch WE: Nutritional therapy in renal failure, in Seldin and Gielbisch (Eds): The Kidney: Physiology and Pathophysiology. 2d ed. New York, Raven Press, 1992, pp 3471-3502.
43. Purkerson ML, Joist JH, Valdes A, Yates J, Morrison A, and Klahr S: Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 82: 193-197, 1985.
44. Yoshida Y, Fogo A, Shiraga H, Glick AD, and Ichikawa L: Serial micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int 33: 855-867, 1988.
45. Yoshida Y, Kawamura T, Ikoma M, Fogo A, and Ichikawa L: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 36: 626-635, 1989.
46. Daniels BS, and Hostetter TH: Adverse effects of growth in the glomerular microcirculation. Am J Physiol 258: F1409-F1416, 1990.
47. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC Jr, and Ichikawa I: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38: 115-123, 1990.
48. Lafferty HM, and Brenner BM: Are glomerular hypertension and "hypertrophy" independent risk factors for progression of renal disease? Semin Nephrol 10: 294-304, 1990.
49. Fries JW, Sandstrom DJ, Meyer TW, and Rennke HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerular sclerosis in the rat. Lab Invest 60: 205-218, 1989.
50. Grond J, Beukers JY, Schilthuis MS, Weening JJ, and Elema JD: Analysis of renal structural and functional features in two rat strains with a different susceptibility to glomerular sclerosis. Lab Invest 54: 77-83, 1986.
51. Anderson S, Rennke HG, and Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1993.
52. Glasser RJ, Velosa JA, and Michael AF: Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest 36: 519-526, 1977.
53. Carvalho-Braga D, Almeida R, Azevedo M, and Amari I: Glomerular hyperfiltration in insulin-dependent diabetes mellitus: no evidence for enhanced activity of the renin-angiotensin-aldosterone system. J Diabetes Complications 5: 126-127, 1991.
54. Geisterfer AA, Peach MJ, and Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749-756, 1988.
55. Klahr S: Low-protein diets and angiotensin-converting enzyme inhibition in progressive renal failure. Am J Kidney Dis 22: 114-119, 1993.
56. Lever AF, and Harrap SB: Essential hypertension: a disorder of growth with origins in childhood? J Hypertens 10: 101-120, 1992.
57. Rennke HG: Structural alterations associated with glomerular hyperfiltration, in Mitch WE, Brenner BM, Stein JH (Eds): The Progressive Nature of Renal Disease. New York, Churchill Livingstone, 1986, pp 111-131.
58. Klahr S, Schreiner G, and Ichikawa I: The progression of renal disease. N Engl J Med 318: 1657-1666, 1988.
59. Bank N, and Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306-1312, 1993.
60. Braun WE: The immunobiology of different types of renal allograft rejection, in Milford EL, Brenner BM, and Stein JH (Eds): Contemporary Issues in Nephrology: Renal Transplantation, New York, Churchill Livingstone, 1989, pp 231-240.
61. Kleinknecht D, Grunfeld JP, Gomez PC, Moreau JF, and Garcia-Torres R: Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int 4: 390-400, 1973.
62. Azuma H, Tullius SG, Heemann UW, and Tilney NL: Nonimmune factors may contribute to chronic rejection of kidney transplants. Transplant Proc 26: 2109-2110, 1994.
63. Tullius SG, Hancock WW, Heemann UW, Azuma H, and Tilney NL: Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 58: 93-99, 1994.
64. Tullius SG, Heemann UW, Hancock WW, Azuma H, and Tilney NL: Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 220: 425-435, 1994.
65. Sporn MB, and Roberts AB: Autocrine secretion-10 years later. Ann Intern Med 117: 408-414, 1992.
66. Shoskes DA, and Halloran PF: Ischemic injury induces altered MHC gene expression in kidney, by an IFN-gamma dependent pathway. Transplant Proc 23: 599-601, 1991.
67. Heemann UW, Tullius SG, Azuma H, Kupiec-Weglinsky J, and Tilney NL: Adhesion molecules and transplantation. Ann Surg 219: 4-12, 1994.
68. Klahr S, Schreiner G, and Ichikawa I: The progression of renal disease. N Engl J Med 318: 1657-1666, 1988.
69. Heemann UW, Tullius SG, Azuma H, Mackenzie HS, Brenner BM, and Tilney NL: Evidence for a beneficial effect of increased functional kidney mass upon chronic kidney rejection in rats. Transplant Proc 26: 2047, 1994.
70. Shimamura T, and Morrison AB: A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 79: 95-106, 1975.
71. Striker GE, Nagle RB, Kohnen PW, and Smuckler EA: Response to unilateral nephrectomy in old rats. Arch Pathol 87: 439-442, 1969.
72. Heppinstall RH: End-stage renal disease, in Heppinstall RB (Ed): Pathology of the Kidney. 4th ed., Boston, Little, Brown, and Company, 1992, pp 713-773.
73. Olivetti G, Anversa P, Rigamaonti W, Vitali-Mazza L, and Loud AV: Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. A light microscope study. J Cell Biol 75: 573-585, 1977.
74. Olivetti G, Anversa P, Melissari M, and Loud AV: Morphometry of the renal corpuscle during postnatal growth and compensatory hypertrophy. Kidney Int 17: 438-454, 1980.
75. Scholey JW, Miller PL, Rennke HG, and Meyer TW: Converting enzyme inhibitor treatment reverses broadening of epithelial foot processes in rats with reduced nephron number. Kidney Int 35: 438, 1989.
76. Shea SM, Raskova J, and Morrison AB: A stereologic study of glomerular hypertrophy in the subtotally nephrectomized rat. Am J Pathol 90: 201-210, 1978.
77. Seyer-Hansen K, Hansen J, and Gunderson HJ: Renal hypertrophy in experimental diabetes. A morphometric study. Diabetologia 18: 501-505, 1980.
78. Griffin K, Bidani A, Schwartz M, and Lewis E: The effects of dietary protein content on glomerular capillary wall tension in remnant kidney model. Proceedings of the 21st annual meeting of the American Society of Nephrology. 1988, p 208A.
79. Oliver J: New direction in renal morphology. A method, its results and its future. Harvey Lecture Series XL, 1945, p 102.
80. Tabei K, Levenson DJ, and Brenner BM: Early enhancement of fluid transport in rabbit proximal straight tubules after loss of contralateral renal excretory function. J Clin Invest 72: 871-881, 1983.
81. Fine LG, and Bradley T: Adaptation of proximal tubular structure and function: insights into compensatory renal hypertrophy. Fed Proc 44: 2723-2727, 1985.
82. Hayslett JP, Kashgarian M, and Epstein FH: Functional correlates of compensatory renal hypertrophy. J Clin Invest 47: 774-799, 1968.
83. Kiprov DD, Colvin RB, and McClusky RT: Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 46: 275-281, 1982.
84. Bhathena DB, Julian BA, McMorrow RG, and Baehler RW: Focal sclerosis of hypertrophied glomeruli in solitary functioning kidneys of humans. Am J Kidney Dis 5: 226-232, 1985.
85. Torres VE, Velosa JA, Holley KE, Kelalis PP, Stickler GB, and Kurtz SB: The progression of vesicoureteral reflux nephropathy. Ann Int Med 92: 776-784, 1980.
86. Baldwin DA: Poststreptococcal glomerulonephritis: a progressive disease? Am J Med 62: 1-11, 1977.
87. Kincaid-Smith P: Analgesic abuse and the kidney. Kidney Int 17: 250-260, 1980.
88. Remuzzi A, Mazerska M, Gephardt GN, Novick AC, Brenner BM, and Remuzzi G: Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int 48: 155-162, 1995.
89. Seiler MW, Terrell CH, Finnegan A, Sterzel RB, and Hoyer JR: Studies of glomerular mesangial uptake and processing of macromolecules. I. Effect of polyvinyl alcohol-induced macrophages on uptake of iron dextran. Lab Invest 54: 616-623, 1986.
90. Sterzel RB, Lovett DH, Stein HD, and Kashgarian M: The mesangium and glomerulonephritis. Klin Wochenschr 60: 1077-1094, 1982.
91. Schlondorff D: The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEBJ 1: 272-281, 1987.
92. Keane WF, and Raij L: Relationship between altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Kidney Int 25: 247, 1984.
93. Stein HD, Feddergreen W, Kashragian M, and Sterzel RB: Role of angiotensin II-induced renal functional changes in mesangial deposition of exogenous ferritin in rats. Lab Invest 49: 270-280, 1983.
94. Olson JL, Hostetter TH, Rennke HG, Brenner BM, and Ven Katachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22: 112-126, 1982.
95. Robson AM, Mor J, Root ER, Jager BV, Shankel SW, Ingelfinger JR, Kienstra RA, and Bricker NS: Mechanisms of proteinuria in nonglomerular disease. Kidney Int 16: 416-429, 1979.
96. Rennke HG: Structural alterations associated with glomerular hyperfiltration, in Mitch WE, Brenner BM, and Stein JH (Eds): The Progressive Nature of Renal Disease. (Contemporary Issues in Nephrology Vol. 14) New York, Churchill-Livingstone, 1986, pp 111-131.
97. Dworkin LD, Hostetter TH, Rennke HG, and Brenner BM: Hemodynamic basis for glomerular injury in rats with deoxycorticosterone-salt hypertension. J Clin Invest 73: 1448-1461, 1984.
98. Rennke HG: The clinical spectrum and pathogenesis of focal glomerulosclerosis. Nephrology Lecture Series-Cleveland Clinic Foundation. Cleveland, Ohio, unpublished.
99. Ellis LB, and Weiss S: Renal function in persons with one kidney. Am J Med Sci 186: 233, 1933.
100. Kretschmer HL: Life after nephrectomy. JAMA 121: 473-478, 1943.
101. Aperia A, Broberger O, Wikstad I, and Wilton P: Renal growth and function in patients nephrectomized in childhood. Acta Paediatr Scand 66: 185-192, 1977.
102. Robitaille P, Mongeau JG, Lortie L, and Sinnassamy P: Long-term follow-up of patients who underwent unilateral nephrectomy in childhood. Lancet 1: 1297-1299, 1985.
103. Smith S, Laprad P, and Grantham J: Long-term effect of uninephrectomy on serum creatinine concentration and arterial blood pressure. Am J Kidney Dis 6: 143-148, 1985.
104. Higashihara E, Horie S, Takeuchi T, Nutahara K, and Aso Y: Long-term consequences of nephrectomy. J Urol 143: 239-243, 1990.
105. Goldstein AE: Longevity following nephrectomy. J Urol 76: 31-41, 1956.
106. Zucchelli P, Cagnoli L, Cassanova S, Donini U, and Pasquali S: Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int 24: 649-653, 1983.
107. Deming CL: The future of the unilaterally nephrectomized patient. J Urol 40: 74-82, 1938.
108. Bennett AH, and Harrison JH: Experience with living familial renal donors. Surg Gynecol Obstet 139: 894-898, 1974.
109. Bergstein J, Michael A Jr, Kellstrand C, Simmons R, and Najarian J: Hemolytic-uremic syndrome in adult sisters. Transplantation 17: 487-490, 1974.
110. Weiland D, Sutherland ER, Chavers B, Simmons RL, Ascher NL, and Najarian JS: Information on 628 living-related kidney donors at a single institution, with long-term follow-up in 472 cases. Transplant Proc 16: 5-7, 1984.
111. Dean S, Rudge CJ, Joyce M, Packham D, and Bewick M: Live related renal transplantation: an analysis of 141 donors. Transplant Proc 14: 65-67, 1982.
112. Tapson JS: End-stage renal failure after donor nephrectomy. Nephron 42: 262-264, 1986.
113. Parfrey PS, Hollomby DJ, Gilmore NJ, Knaack J, Schur PH, and Guttman RD: Glomerular sclerosis in a renal isograft and identical twin donor. A family study. Transplantation 38: 343-346, 1984.
114. Miller IJ, Suthanthiran M, Riggio RR, Williams JJ, Riehle RA, Vaughan ED, Stubenbord WT, Mouradian J, Cheigh JS, and Stenzel KH: Impact of renal donation: long-term clinical and biochemical follow-up of living donors in a single center. Am J Med 79: 201-208, 1985.
115. Talseth T, Fauchald P, Skred S, Djoseland O, Berg KJ, Stenstrom J, Heilo A, Brodwall EK, and Flatmark A: Long-term blood pressure and renal function in kidney donors. Kidney Int 29: 1072-1076, 1986.
116. ter Wee PM, Tegzess AM, and Donker AJ: The effect of low-dose dopamine on renal function in uninephrectomized patients: special emphasis on kidney donors before and after nephrectomy. Clin Nephrol 28: 211-216, 1987.
117. Tapson JS, Mansy H, Marshall SM, Tisdall SR, and Wilkinson R: Renal functional reserve in kidney donors. Q J M 60: 725-732, 1986.
118. Cassidy MJ, and Beck RM: Renal functional reserve in live related kidney donors. Am J Kidney Dis 11: 468-472, 1988.
119. Rodriguez-Iturbe B, Herrera J, and Garcia R: Response to acute protein load in kidney donors and in apparently normal postacute glomerulonephritis patients: evidence for glomerular hyperfiltration. Lancet 2: 461-464, 1985.
120. Buszta C, Steinmuller DR, Novick AC, Schreiber MJ, Cunningham R, Popowniak KL, Streem SB, Steinhilber D, and Braun WE: Pregnancy after donor nephrectomy. Transplantation 40: 651-654, 1985.
121. Steckler RE, Riehle RA Jr, and Vaughan ED Jr: Hyperfiltration-induced renal injury in normal man: myth or reality. J Urol 144: 1323-1327, 1990.
122. Brenner BM, Cohen RA, and Milford EL: In renal transplantation, one size may not fit all. J Am Soc Nephrol 3: 162-169, 1992.
123. Hayes JM, Steinmuller DR, Streem SB, and Novick AC: The development of proteinuria and focal-segmental glomerulosclerosis in recipients of pediatric donor kidneys. Transplantation 52: 813-817, 1991.
124. Terasaki PI, Koyama H, Cecka JM, and Gjertson DW: The hyperfiltration hypothesis in human renal transplantation. Transplantation 57: 1450-1454, 1994.
125. Solomon LR, Mallick NP, and Lawler W: Progressive renal failure in a remnant kidney. Br Med J 291: 1610-1611, 1985.
126. Stahl RA, Low I, and Schoeppe W: Progressive renal failure in a patient after one and two-thirds nephrectomy. Klin Wochenschr 66: 508-510, 1988.
127. Lhotta K, Eberle H, Konig P, and Dittrich P: Renal function after tumor enucleation in a solitary kidney. Am J Kidney Dis 17: 266-270, 1991.
128. Novick AC, Gephardt G, Guz B, Steinmuller D, and Tubbs RR: Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325: 1058-1062, 1991.
129. Novick AC, and Schrieber MJ: The effect of angiotensin-converting-enzyme inhibition on nephropathy in patients with a remnant kidney. Urology 1996 (in press).
130. Arant BS Jr: Vesicoureteric reflux and renal injury. Am J Kidney Dis 17: 491-511, 1991.
131. Maschio G, Oldrizzi L, Tessitore N, D'Angelo A, Valvo E, Lupo A, Loschiavo C, Fabris A, Gammaro L, Rugiu C, et al: Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int 22: 371-376, 1982.
132. Parving HH, Smidt UM, Andersen AR, and Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175-1179, 1983.
133. Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, and Maresca MC: The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis 21(suppl 2): 79-83, 1993.